- Home
- CRGO vs ACRS Comparison
CRGO vs ACRS Comparison
Compare CRGO & ACRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRGO | ACRS |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.4M | 230.8M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | CRGO | ACRS |
|---|---|---|
| Price | $3.12 | $3.18 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.75 |
| AVG Volume (30 Days) | 74.6K | ★ 1.3M |
| Earning Date | 11-17-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $28,642,000.00 | $15,742,000.00 |
| Revenue This Year | $26.59 | N/A |
| Revenue Next Year | $23.43 | $6.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 27.55 | N/A |
| 52 Week Low | $1.72 | $1.05 |
| 52 Week High | $4.42 | $3.57 |
Technical Indicators
Market Signals| Indicator | CRGO | ACRS |
|---|---|---|
| Relative Strength Index (RSI) | 43.82 | 62.62 |
| Support Level | $3.04 | $3.12 |
| Resistance Level | $3.22 | $3.48 |
| Average True Range (ATR) | 0.14 | 0.21 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 24.14 | 67.23 |
Price Performance
Historical ComparisonAbout CRGO Freightos Limited Ordinary shares
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.
About ACRS Aclaris Therapeutics Inc.
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.